Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1671850377;50378;50379 chr2:178612373;178612372;178612371chr2:179477100;179477099;179477098
N2AB1507745454;45455;45456 chr2:178612373;178612372;178612371chr2:179477100;179477099;179477098
N2A1415042673;42674;42675 chr2:178612373;178612372;178612371chr2:179477100;179477099;179477098
N2B765323182;23183;23184 chr2:178612373;178612372;178612371chr2:179477100;179477099;179477098
Novex-1777823557;23558;23559 chr2:178612373;178612372;178612371chr2:179477100;179477099;179477098
Novex-2784523758;23759;23760 chr2:178612373;178612372;178612371chr2:179477100;179477099;179477098
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGC
  • RefSeq wild type template codon: CCG
  • Domain: Fn3-9
  • Domain position: 68
  • Structural Position: 100
  • Q(SASA): 0.3158
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/V None None 1.0 D 0.841 0.662 0.863703880688 gnomAD-4.0.0 1.59394E-06 None None None None N None 0 0 None 0 0 None 0 0 0 1.43332E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.7403 likely_pathogenic 0.8525 pathogenic -0.52 Destabilizing 1.0 D 0.72 prob.delet. D 0.567443663 None None N
G/C 0.8999 likely_pathogenic 0.9508 pathogenic -0.94 Destabilizing 1.0 D 0.819 deleterious D 0.763149646 None None N
G/D 0.8401 likely_pathogenic 0.9021 pathogenic -0.631 Destabilizing 1.0 D 0.809 deleterious N 0.483451209 None None N
G/E 0.925 likely_pathogenic 0.9663 pathogenic -0.765 Destabilizing 1.0 D 0.856 deleterious None None None None N
G/F 0.9782 likely_pathogenic 0.9874 pathogenic -1.078 Destabilizing 1.0 D 0.816 deleterious None None None None N
G/H 0.9583 likely_pathogenic 0.9798 pathogenic -0.839 Destabilizing 1.0 D 0.82 deleterious None None None None N
G/I 0.9712 likely_pathogenic 0.9886 pathogenic -0.463 Destabilizing 1.0 D 0.827 deleterious None None None None N
G/K 0.9741 likely_pathogenic 0.9898 pathogenic -0.98 Destabilizing 1.0 D 0.855 deleterious None None None None N
G/L 0.9655 likely_pathogenic 0.9813 pathogenic -0.463 Destabilizing 1.0 D 0.843 deleterious None None None None N
G/M 0.9677 likely_pathogenic 0.9845 pathogenic -0.42 Destabilizing 1.0 D 0.819 deleterious None None None None N
G/N 0.6857 likely_pathogenic 0.779 pathogenic -0.604 Destabilizing 1.0 D 0.799 deleterious None None None None N
G/P 0.9948 likely_pathogenic 0.9982 pathogenic -0.445 Destabilizing 1.0 D 0.851 deleterious None None None None N
G/Q 0.9374 likely_pathogenic 0.9731 pathogenic -0.878 Destabilizing 1.0 D 0.847 deleterious None None None None N
G/R 0.9657 likely_pathogenic 0.9854 pathogenic -0.559 Destabilizing 1.0 D 0.853 deleterious D 0.649010727 None None N
G/S 0.5198 ambiguous 0.655 pathogenic -0.841 Destabilizing 1.0 D 0.795 deleterious D 0.553032025 None None N
G/T 0.8087 likely_pathogenic 0.9138 pathogenic -0.897 Destabilizing 1.0 D 0.852 deleterious None None None None N
G/V 0.9401 likely_pathogenic 0.9746 pathogenic -0.445 Destabilizing 1.0 D 0.841 deleterious D 0.657888672 None None N
G/W 0.9736 likely_pathogenic 0.9872 pathogenic -1.259 Destabilizing 1.0 D 0.819 deleterious None None None None N
G/Y 0.9539 likely_pathogenic 0.9757 pathogenic -0.9 Destabilizing 1.0 D 0.811 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.